Skip to main content


Log in

Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript


The clinical features and prognostic factor of lymphoma-associated hemophagocytic syndrome (LAHS), diagnosed according to World Health Organization classification, were investigated by reviewing the clinical records of 29 patients between September 1994 and September 2006. Compared with patients with T or natural killer (NK)/T cell LAHS, patients with B cell LAHS were older (p = 0.022), were less likely to exhibit disseminated intravascular coagulation (DIC; p = 0.011), and had less direct involvement of bone marrow (p = 0.03). Clinical response was achieved in 15 (65.2%) and complete remission (CR) was achieved in 4 (17%) of 23 patients who received chemotherapy. Four patients received high-dose chemotherapy and autologous stem cell transplantation (A-SCT), and three of these four patients showed CR. The median survival was 36 days (95%CI, 20.2–51.8). Univariate analysis showed that poor performance status (p = 0.028), T or NK/T cell lymphoma (p = 0.016), presence of jaundice (p = 0.063), the presence of DIC (p = 0.002), and poor clinical response to treatment (p < 0.001) predicted poor overall survival. These data suggest that the clinical features differ significantly between B cell LAHS and T or NK/T cell LAHS. Intensive treatment including high-dose chemotherapy and A-SCT should be investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others


  1. Allory Y, Challine D, Haioun C, Copie-Bergman C, Delfau-Larue MH, Boucher E, Charlotte F, Fabre M, Michel M, Gaulard P (2001) Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution. Am J Surg Pathol 25:865–874

    Article  PubMed  CAS  Google Scholar 

  2. Bhagwati NS, Oiseth SJ, Abebe LS, Wiernik PH (2004) Intravascular lymphoma associated with hemophagocytic syndrome: a rare but aggressive clinical entity. Ann Hematol 83:247–250

    Article  PubMed  Google Scholar 

  3. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579–586

    Article  PubMed  Google Scholar 

  4. Cheung MM, Chan JK, Lau WH, Foo W, Chan PT, Ng CS, Ngan RK (1998) Primary non-Hodgkin’s lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 16:70–77

    PubMed  CAS  Google Scholar 

  5. Falini B, Pileri S, De Solas I, Martelli MF, Mason DY, Delsol G, Gatter KC, Fagioli M (1990) Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 75:434–444

    PubMed  CAS  Google Scholar 

  6. Fisman DN (2000) Hemophagocytic syndromes and infection. Emerg Infect Dis 6:601–608

    Article  PubMed  CAS  Google Scholar 

  7. Florena AM, Iannitto E, Quintini G, Franco V (2002) Bone marrow biopsy in hemophagocytic syndrome. Virchows Arch 441:335–344

    Article  PubMed  Google Scholar 

  8. Imashuku S (1997) Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 66:135–151

    Article  PubMed  CAS  Google Scholar 

  9. Kumakura S (2005) Hemophagocytic syndrome. Intern Med 44:278–280

    Article  PubMed  Google Scholar 

  10. Lee PS, Hwang WS (2002) Aggressive natural killer cell lymphoma/leukemia. Zhonghua Yi Xue Za Zhi (Taipei) 65:622–626

    Google Scholar 

  11. Majluf-Cruz A, Sosa-Camas R, Perez-Ramirez O, Rosas-Cabral A, Vargas-Vorackova F, Labardini-Mendez J (1998) Hemophagocytic syndrome associated with hematological neoplasias. Leuk Res 22:893–898

    Article  PubMed  CAS  Google Scholar 

  12. Miyahara M, Sano M, Shibata K, Matsuzaki M, Ibaraki K, Shimamoto Y, Tokunaga O (2000) B-cell lymphoma-associated hemophagocytic syndrome: clinicopathological characteristics. Ann Hematol 79:378–388

    Article  PubMed  CAS  Google Scholar 

  13. Murase T, Nakamura S, Tashiro K, Suchi T, Hiraga J, Hayasaki N, Kimura M, Murakami M, Mizoguchi Y, Suzuki T, Saito H (1997) Malignant histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature. Br J Haematol 99:656–664

    Article  PubMed  CAS  Google Scholar 

  14. Murase T, Yamaguchi M, Suzuki R, Okamoto M, Sato Y, Tamaru J, Kojima M, Miura I, Mori N, Yoshino T, Nakamura S (2007) Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 109:478–485

    Article  PubMed  CAS  Google Scholar 

  15. Ohno T, Miyake N, Hada S, Hirose Y, Imura A, Hori T, Uchiyama T, Saiga T, Mizumoto T, Furukawa H (1998) Hemophagocytic syndrome in five patients with Epstein–Barr virus negative B-cell lymphoma. Cancer 82:1963–1972

    Article  PubMed  CAS  Google Scholar 

  16. Shimazaki C, Inaba T, Shimura K, Okamoto A, Takahashi R, Hirai H, Sudo Y, Ashihara E, Adachi Y, Murakami S, Saigo K, Fujita N, Nakagawa M (1999) B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. Br J Haematol 104:672–679

    Article  PubMed  CAS  Google Scholar 

  17. Song SY, Kim WS, Ko YH, Kim K, Lee MH, Park K (2002) Aggressive natural killer cell leukemia: clinical features and treatment outcome. Haematologica 87:1343–1345

    PubMed  Google Scholar 

  18. Su IJ, Hsu YH, Lin MT, Cheng AL, Wang CH, Weiss LM (1993) Epstein–Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 72:2019–2027

    Article  PubMed  CAS  Google Scholar 

  19. Tsuchiyama J, Imajo K, Yoshino T, Nanba N, Toyota A, Yoshida C, Fujii K, Kondo E, Okazuka K, Hashimoto S, Toba K, Fuse I, Aizawa Y, Harada M, Tsubota T (2002) High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases. Ann Hematol 81:588–592

    Article  PubMed  CAS  Google Scholar 

  20. Wilson MS, Weiss LM, Gatter KC, Mason DY, Dorfman RF, Warnke RA (1990) Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer 66:530–536

    Article  PubMed  CAS  Google Scholar 

  21. Wong KF, Chan JK (1992) Reactive hemophagocytic syndrome—a clinicopathologic study of 40 patients in an Oriental population. Am J Med 93:177–180

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Won Seog Kim.

Additional information

A-Reum Han and Hye Ran Lee contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Han, AR., Lee, H.R., Park, BB. et al. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. Ann Hematol 86, 493–498 (2007).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: